Ketamine to treat ALS (Lou Gehrig’s Disease) – FDA Grants Rare Disease Designation The U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for ketamine in the treatment of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. ALS – Lou Gherig’s Disease ALS is a progressive neuromuscular disease with a poor Read More …